These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 31286138)
1. The Role of APAL/ST8SIA6-AS1 lncRNA in PLK1 Activation and Mitotic Catastrophe of Tumor Cells. Luo ML; Li J; Shen L; Chu J; Guo Q; Liang G; Wu W; Chen J; Chen R; Song E J Natl Cancer Inst; 2020 Apr; 112(4):356-368. PubMed ID: 31286138 [TBL] [Abstract][Full Text] [Related]
2. LncRNA ST8SIA6-AS1 promotes proliferation, migration and invasion in breast cancer through the p38 MAPK signalling pathway. Fang K; Hu C; Zhang X; Hou Y; Gao D; Guo Z; Li L Carcinogenesis; 2020 Sep; 41(9):1273-1281. PubMed ID: 31784750 [TBL] [Abstract][Full Text] [Related]
3. AIBp regulates mitotic entry and mitotic spindle assembly by controlling activation of both Aurora-A and Plk1. Chou CH; Loh JK; Yang MC; Lin CC; Hong MC; Cho CL; Chou AK; Wang CH; Lieu AS; Howng SL; Hsu CM; Hong YR Cell Cycle; 2015; 14(17):2764-76. PubMed ID: 26114227 [TBL] [Abstract][Full Text] [Related]
4. Global assessment of its network dynamics reveals that the kinase Plk1 inhibits the phosphatase PP6 to promote Aurora A activity. Kettenbach AN; Schlosser KA; Lyons SP; Nasa I; Gui J; Adamo ME; Gerber SA Sci Signal; 2018 May; 11(530):. PubMed ID: 29764989 [TBL] [Abstract][Full Text] [Related]
5. Profiling of specific long non-coding RNA signatures identifies ST8SIA6-AS1 AS a novel target for breast cancer. Chen Z; Huang J; Feng Y; Li Z; Jiang Y J Gene Med; 2021 Feb; 23(2):e3286. PubMed ID: 33037712 [TBL] [Abstract][Full Text] [Related]
6. The Mitotic Cancer Target Polo-Like Kinase 1: Oncogene or Tumor Suppressor? de Cárcer G Genes (Basel); 2019 Mar; 10(3):. PubMed ID: 30862113 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic relevance of the protein phosphatase 2A in cancer. Cunningham CE; Li S; Vizeacoumar FS; Bhanumathy KK; Lee JS; Parameswaran S; Furber L; Abuhussein O; Paul JM; McDonald M; Templeton SD; Shukla H; El Zawily AM; Boyd F; Alli N; Mousseau DD; Geyer R; Bonham K; Anderson DH; Yan J; Yu-Lee LY; Weaver BA; Uppalapati M; Ruppin E; Sablina A; Freywald A; Vizeacoumar FJ Oncotarget; 2016 Sep; 7(38):61544-61561. PubMed ID: 27557495 [TBL] [Abstract][Full Text] [Related]
8. Co-inhibition of polo-like kinase 1 and Aurora kinases promotes mitotic catastrophe. Li J; Hong MJ; Chow JP; Man WY; Mak JP; Ma HT; Poon RY Oncotarget; 2015 Apr; 6(11):9327-40. PubMed ID: 25871386 [TBL] [Abstract][Full Text] [Related]
9. Long non‑coding RNA ZEB2‑AS1 affects cell proliferation and apoptosis via the miR‑122‑5p/PLK1 axis in acute myeloid leukemia. Guan J; Liu P; Wang A; Wang B Int J Mol Med; 2020 Oct; 46(4):1490-1500. PubMed ID: 32700753 [TBL] [Abstract][Full Text] [Related]
10. Regulation of cell apoptosis and proliferation in pancreatic cancer through PI3K/Akt pathway via Polo-like kinase 1. Mao Y; Xi L; Li Q; Cai Z; Lai Y; Zhang X; Yu C Oncol Rep; 2016 Jul; 36(1):49-56. PubMed ID: 27220401 [TBL] [Abstract][Full Text] [Related]
11. [Effect of antisense RNA targeting Polo-like kinase 1 on cell cycle of lung cancer cell line A549]. Zhou Q; Bai M; Su Y Ai Zheng; 2005 Feb; 24(2):149-54. PubMed ID: 15694023 [TBL] [Abstract][Full Text] [Related]
12. lncRNA CCAT1 is a biomarker for the proliferation and drug resistance of esophageal cancer via the miR-143/PLK1/BUBR1 axis. Hu M; Zhang Q; Tian XH; Wang JL; Niu YX; Li G Mol Carcinog; 2019 Dec; 58(12):2207-2217. PubMed ID: 31544294 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of polo-like kinase 1 leads to the suppression of osteosarcoma cell growth in vitro and in vivo. Liu X; Choy E; Harmon D; Yang S; Yang C; Mankin H; Hornicek FJ; Duan Z Anticancer Drugs; 2011 Jun; 22(5):444-53. PubMed ID: 21399492 [TBL] [Abstract][Full Text] [Related]
14. Essential Role of Polo-like Kinase 1 (Plk1) Oncogene in Tumor Growth and Metastasis of Tamoxifen-Resistant Breast Cancer. Jeong SB; Im JH; Yoon JH; Bui QT; Lim SC; Song JM; Shim Y; Yun J; Hong J; Kang KW Mol Cancer Ther; 2018 Apr; 17(4):825-837. PubMed ID: 29437878 [TBL] [Abstract][Full Text] [Related]
15. Bora and Aurora-A continue to activate Plk1 in mitosis. Bruinsma W; Macurek L; Freire R; Lindqvist A; Medema RH J Cell Sci; 2014 Feb; 127(Pt 4):801-11. PubMed ID: 24338364 [TBL] [Abstract][Full Text] [Related]
16. Influence of chk1 and plk1 silencing on radiation- or cisplatin-induced cytotoxicity in human malignant cells. Gao Q; Huang X; Tang D; Cao Y; Chen G; Lu Y; Zhuang L; Wang S; Xu G; Zhou J; Ma D Apoptosis; 2006 Oct; 11(10):1789-800. PubMed ID: 16927022 [TBL] [Abstract][Full Text] [Related]
17. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells. Zhang Y; Du XL; Wang CJ; Lin DC; Ruan X; Feng YB; Huo YQ; Peng H; Cui JL; Zhang TT; Wang YQ; Zhang H; Zhan QM; Wang MR Gastroenterology; 2012 Mar; 142(3):521-530.e3. PubMed ID: 22108192 [TBL] [Abstract][Full Text] [Related]
18. A Synthetic Dosage Lethal Genetic Interaction Between CKS1B and PLK1 Is Conserved in Yeast and Human Cancer Cells. Reid RJ; Du X; Sunjevaric I; Rayannavar V; Dittmar J; Bryant E; Maurer M; Rothstein R Genetics; 2016 Oct; 204(2):807-819. PubMed ID: 27558135 [TBL] [Abstract][Full Text] [Related]
19. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells. Li W; Sun M; Zang C; Ma P; He J; Zhang M; Huang Z; Ding Y; Shu Y Cell Death Dis; 2016 May; 7(5):e2225. PubMed ID: 27195672 [TBL] [Abstract][Full Text] [Related]
20. Normal cells, but not cancer cells, survive severe Plk1 depletion. Liu X; Lei M; Erikson RL Mol Cell Biol; 2006 Mar; 26(6):2093-108. PubMed ID: 16507989 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]